Screener
Adaptive Biotechnologies ADPT Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Adaptive Biotechnologies’s reported figures.
The source filing: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:30 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206546
FAQ
- What is Adaptive Biotechnologies's invested capital?
- Adaptive Biotechnologies (ADPT) reported invested capital of $346.94M in Q1 2026.
- How has Adaptive Biotechnologies's invested capital changed year-over-year?
- Adaptive Biotechnologies's invested capital decreased by 3.7% year-over-year, from $360.24M to $346.94M.
- What is the long-term trend for Adaptive Biotechnologies's invested capital?
- Over 5 years (2020 to 2025), Adaptive Biotechnologies's invested capital has grown at a -13.2% compound annual growth rate (CAGR), from $727.69M to $358.65M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Adaptive Biotechnologies's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude